Our Team — Architects of Excellence | Zolovex
Our Team

Architects of excellence.

Systematic investing is an engineering discipline before it is a financial one. Zolovex is built by the people below — leadership, quantitative strategy, and AI research working to one standard: preserve capital first, then pursue growth.

Leadership
Pedro Murillo, Founder & CEO
Leadership

Pedro Murillo

Founder & CEO

Our CEO didn’t come from a life of privilege or inside access to markets — they arrived in finance through hands-on work and close collaboration with industry practitioners. By working directly with brokers, advisors, and algorithmic teams, they saw that disciplined, systematic capital management was largely reserved for institutions with data, engineers, and infrastructure. Retail options were often discretionary, opaque, or overpromised. That observation drove the decision to build Zolovex: to bring institutional rigor to everyday investors while preserving their control.

Product Development

The research and engineering group behind the signals — translating market structure into models that hold up outside a backtest.

Lucas Morreti, Quant–Investment Strategist

Lucas Morreti

Quant–Investment Strategist

Builds and validates the factor research behind the equity engine — momentum, mean-reversion, and regime sensitivity across multiple horizons.

Ashar Patel, Quant–Investment Strategist

Ashar Patel

Quant–Investment Strategist

Focuses on risk budgeting, position sizing, and stress testing — making sure a strategy's downside behaviour is understood before it goes live.

Jorge Cruz, AI Quantitative Researcher

Jorge Cruz

AI Quantitative Researcher

Works on the machine learning components — kept constrained for stability and explainability, so every prediction carries an attribution rather than a black box.

Ready to begin?

See exactly how the engines trade.

Three quick questions to match you to the right engine, then a 15-minute walkthrough on real accounts. No obligation.

Take the Questionnaire →